Recombinant Proteins
Modified or manipulated proteins encoded by recombinant DNA and suitable for a variety of purposes including the modification of gene sequences, mass protein production, and the manufacture of commercial products.
Species
- (2)
- (1)
- (11)
- (1,878)
- (102)
- (1)
- (1)
- (46)
- (8)
- (15)
- (1)
- (331)
- (1)
- (1)
- (28,503)
- (1)
- (8)
- (3)
- (15)
- (1)
- (3)
- (6)
- (1)
- (7)
- (1)
- (3)
- (2)
- (3)
- (4)
- (3)
- (2)
- (5)
- (3)
- (3)
- (2)
- (1)
- (4)
- (1)
- (29,188)
- (202)
- (16)
- (15)
- (8)
- (4)
- (1)
- (3)
- (2)
- (6)
- (218)
- (4)
- (898)
- (1)
- (14)
- (1)
- (53)
- (2)
- (2)
- (1)
- (42)
- (9)
- (46)
- (27)
- (2)
- (52)
- (138)
- (142)
- (13)
- (12)
- (2)
- (8)
- (2)
- (154)
- (4)
- (3)
- (3)
- (2)
- (2)
- (5)
- (14)
- (30,024)
- (4,517)
- (2)
- (4)
For Use With (Application)
- (1)
- (2,853)
- (1)
- (28,533)
- (1)
- (30)
- (65)
- (4,708)
- (24)
- (8)
- (2)
- (8)
- (21,580)
- (2)
- (4)
- (2)
- (2)
- (12)
- (56)
- (2)
- (2)
- (2)
- (1)
- (2)
- (2)
- (3)
- (1)
- (5)
- (248)
- (22,897)
- (1)
- (16)
- (1)
- (28)
- (4)
- (51,421)
- (23)
- (2)
- (4)
- (32)
- (703)
- (6)
- (3)
- (200)
- (1)
- (1)
- (129)
- (5,167)
- (1,567)
- (3)
- (62)
- (7)
- (3)
- (4)
- (1)
- (19,643)
- (20)
- (31)
- (19)
- (1)
- (3)
- (451)
- (16)
- (3)
- (124)
- (150)
- (97)
- (2)
- (14)
- (4)
- (1)
- (1,598)
- (2)
- (4)
- (1)
- (19)
- (19)
- (11)
- (2)
- (10)
- (2)
- (9)
- (3)
- (4,210)
- (4)
- (1)
- (8)
- (1)
- (1)
- (4)
- (3)
- (1)
- (1)
- (1)
- (1)
- (47,861)
- (198)
- (15)
- (2)
- (1)
- (197)
- (62)
- (6)
- (1)
- (6)
- (22)
- (1)
- (6)
- (197)
- (1)
- (8,221)
- (6)
- (4)
- (13)
- (2)
- (4)
- (14)
- (5)
- (8)
- (1)
- (50,942)
Recombinant
- (10)
- (67,645)
- (18)
Form
- (3)
- (19)
- (49,935)
- (7,233)
- (3,620)
- (136)
- (13)
- (3,410)
Conjugate
- (2)
- (1)
- (66)
- (1)
- (4)
- (2)
- (11)
- (63)
- (1)
- (4)
- (4)
- (1)
- (401)
- (1)
- (1)
- (2)
- (2)
- (1)
- (1)
- (4)
- (2)
- (104)
- (12)
- (2)
- (3)
- (2)
- (2)
- (1)
- (14)
- (677)
- (1)
- (2)
- (3)
- (46)
- (42,345)
- (2)
- (2)
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | PDGF-BB |
| Molecular Weight (g/mol) | 24.3 kDa |
| Gene Symbol | PDGFB |
| Endotoxin Concentration | <1 EU/ μg |
| Sequence | SLGSLTIAEP AMIAECKTRT EVFEISRRLI DRTNANFLVW PPCVEVQRCS GCCNNRNVQC RPTQVQLRPV QVRKIEIVRK KPIFKKATVT LEDHLACKCE TVAAARPVT |
| Expression System | E. coli |
| For Use With (Application) | ELISA,Functional Assay,Western Blot |
| Source | E. coli |
| Name | Human PDGF-BB |
| Accession Number | P01127 |
| Regulatory Status | RUO |
| Gene Alias | becaplermin; c-sis; FLJ12858; H-PDGF-BB; IBGC5; PDGF; pdgf protein; PDGF subunit B; PDGF, B chain; PDGF2; PDGF-2; PDGFB; PDGF-B; platelet derived growth factor subunit B; platelet derived growth factor, B polypeptide; platelet-derived growth factor 2; platelet-derived growth factor B; platelet-derived growth factor B chain; platelet-derived growth factor beta; platelet-derived growth factor beta polypeptide; platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog); platelet-derived growth factor subunit B; platelet-derived growth factor, beta polypeptide (oncogene SIS); Platelet-derived growth factor, same as Sis (Simian sarcoma viral oncogene homologue, c-sis); proto-oncogene c-Sis; Sis; SSV |
| Biological Activity | Determined by the dose-dependent stimulation of the proliferation of Balb/c 3T3 cells.The expected ED50 for this effect is 1.0-3.0 ng/ml |
| Gene ID (Entrez) | 5155 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |
| Protein Family | Growth Factors & Receptors |
|---|---|
| Purity or Quality Grade | >95% by SDS-PAGE |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | EGF |
| Molecular Weight (g/mol) | 6.2 kDa |
| Endotoxin Level | <0.1 ng/μg |
| Activity | ED50 < 0.4 ng/mL; determined by the dose-dependent proliferation of mouse BALB/3T3 cells. |
| Endotoxin Concentration | <0.1 ng/μg |
| Expression System | E. coli |
| For Use With (Application) | Control,ELISA,Functional Assay,Immunohistochemistry,Western Blot |
| Name | Human EGF |
| Purification Method | Purified |
| Gene Alias | AI790464; beta-urogastrone; EGF; Epidermal growth factor; epidermal growth factor (beta-urogastrone); epidermal growth factor precursor; H-EGF; HOMG4; Pro-epidermal growth factor; Pro-epidermal growth factor precursor (EGF); sb:eu639; URG; Urogastrone |
| Protein Form | Recombinant, Ligand |
| Biological Activity | ED50 < 0.4 ng/mL; determined by the dose-dependent proliferation of mouse BALB/3T3 cells. |
| Formulation | Protein with no preservative |
| Classification | Carrier-Free |
| Research Category | Stem Cell Research, Oncology |
| Species | Human |
| Recombinant | Recombinant |
| Shipping Condition | Wet Ice |
| Content And Storage | 4°C |
| Gene Symbol | EGF |
| Storage Requirements | 4°C |
| Protein Subtype | EGF (Epidermal Growth Factor) |
| Accession Number | P01133 |
| Regulatory Status | RUO |
| Product Type | Protein |
| Gene ID (Entrez) | 1950 |
| Product Line | Gibco™ |
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | IL-4 |
| Molecular Weight (g/mol) | 15.1 kDa |
| Gene Symbol | Il4 |
| Endotoxin Concentration | <1 EU/ μg |
| Sequence | MHKCDITLQE IIKTLNSLTE QKTLCTELTV TDIFAASKNT TEKETFCRAA TVLRQFYSHH EKDTRCLGAT AQQFHRHKQL IRFLKRLDRN LWGLAGLNSC PVKEANQSTL ENFLERLKTI MREKYSKCSS |
| Expression System | E. coli |
| For Use With (Application) | ELISA,Functional Assay,Western Blot |
| Source | E. coli |
| Name | Human IL-4 |
| Accession Number | P05112 |
| Regulatory Status | RUO |
| Gene Alias | B cell growth factor 1; B_cell stimulatory factor 1; B-cell growth factor 1; B-cell IgG differentiation factor; B-cell stimulatory factor 1; BCGF1; BCGF-1; binetrakin; BSF1; BSF-1; cytokine; H-IL-4; IGG1 induction factor; IL2; IL4; Il-4; Il4e12; ILN; Interleukin; interleukin 4; interleukin 4 variant 2; interleukin 4 variant IL-4 delta2; interleukin 4 variant IL-4 delta3; interleukin 4 variant IL-4 int2A; interleukin 4 variant IL-4 int3A; interleukin 4 variant IL-4 int3B; Interleukin4; interleukin-4; interleukin-4 precursor; lymphocyte stimulatory factor 1; MGC79402; M-IL-4; Pitrakinra |
| Biological Activity | The ED50 as determined by the dose-dependent stimulation of human TF-1 cells is ≤ 0.2 ng/ml, corresponding to a specific activity of ≥ 5 x 10^6 units/mg |
| Gene ID (Entrez) | 3565 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |